
Accession Therapeutics
Developer of an immuno-oncology therapeutics platform designed to make oncology therapeutics targeted and potent. The company specializes in immunotherapy that is specific, broad in action to kill all...
Valuation
$0
Share Price
N/A
Total Raised
$107.9M
Last Round
N/A